167 related articles for article (PubMed ID: 37021578)
1. Corrected MRI Pulmonary Transit Time for Identification of Combined Precapillary and Postcapillary Pulmonary Hypertension in Patients With Left Heart Disease.
Gong C; Guo X; Wan K; Chen C; Chen X; Guo J; He J; Yin L; Wen B; Pu S; Chen Y
J Magn Reson Imaging; 2023 May; 57(5):1518-1528. PubMed ID: 37021578
[TBL] [Abstract][Full Text] [Related]
2. [Functional characterization of patients with isolated post-capillary or combined post-capillary and pre-capillary pulmonary hypertension].
Held M; Weiner S; Walthelm J; Joa F; Hoffmann J; Güder G; Pfeuffer-Jovic E
Pneumologie; 2022 Oct; 76(10):689-696. PubMed ID: 36257308
[TBL] [Abstract][Full Text] [Related]
3. Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
Caravita S; Faini A; Carolino D'Araujo S; Dewachter C; Chomette L; Bondue A; Naeije R; Parati G; Vachiéry JL
PLoS One; 2018; 13(6):e0199164. PubMed ID: 29920539
[TBL] [Abstract][Full Text] [Related]
4. Impact of Combined Pre and Postcapillary Pulmonary Hypertension on Survival after Transcatheter Aortic Valve Implantation.
Sultan I; Fukui M; Bianco V; Brown JA; Kliner DE; Hickey G; Thoma FW; Lee JS; Schindler JT; Kilic A; Gleason TG; Cavalcante JL
Am J Cardiol; 2020 Sep; 131():60-66. PubMed ID: 32713655
[TBL] [Abstract][Full Text] [Related]
5. [Functional characterization of patients with isolated post-capillary or combined post-capillary and pre-capillary pulmonary hypertension].
Held M; Weiner S; Walthelm J; Joa F; Hoffmann J; Güder G; Pfeuffer-Jovic E
Dtsch Med Wochenschr; 2021 Oct; 146(21):e88-e94. PubMed ID: 34670324
[TBL] [Abstract][Full Text] [Related]
6. Association of Pulmonary Transit Time and Pulmonary Blood Volume From First-Pass Perfusion Cardiac MRI With Diastolic Dysfunction and Left Ventricle Deformation in Restrictive Cardiomyopathy.
Gao Y; Min CY; Jiang YN; Shi R; Guo YK; Xu HY; Yang ZG; Li Y
J Magn Reson Imaging; 2024 Feb; ():. PubMed ID: 38353473
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications.
Omote K; Sorimachi H; Obokata M; Reddy YNV; Verbrugge FH; Omar M; DuBrock HM; Redfield MM; Borlaug BA
Eur Heart J; 2022 Sep; 43(36):3417-3431. PubMed ID: 35796488
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension and ventilation during exercise: Role of the pre-capillary component.
Caravita S; Faini A; Deboeck G; Bondue A; Naeije R; Parati G; Vachiéry JL
J Heart Lung Transplant; 2017 Jul; 36(7):754-762. PubMed ID: 28131663
[TBL] [Abstract][Full Text] [Related]
9. [Pulmonary hypertension associated with left heart disease (group 2)].
Schmidt KH; Bikou O; Blindt R; Bruch L; Felgendreher R; Hohenforst-Schmidt W; Holt S; Ladage D; Pfeuffer-Jovic E; Rieth A; Schmeisser A; Schnitzler K; Stadler S; Steringer-Mascherbauer R; Yogeswaran A; Kuebler WM
Pneumologie; 2023 Nov; 77(11):926-936. PubMed ID: 37963482
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary Hypertension Due to Left Heart Disease-A Practical Approach to Diagnosis and Management.
Lee F; Mielniczuk LM
Can J Cardiol; 2021 Apr; 37(4):572-584. PubMed ID: 33217522
[TBL] [Abstract][Full Text] [Related]
11. Impact of the new pulmonary hypertension definition on long-term mortality in patients with severe aortic stenosis undergoing valve replacement.
Maeder MT; Weber L; Weilenmann D; Chronis J; Joerg L; Pohle S; Haager PK; Brutsche M; Neumann T; Schoch OD; Rickli H
Clin Cardiol; 2021 Sep; 44(9):1276-1285. PubMed ID: 34219245
[TBL] [Abstract][Full Text] [Related]
12. First-pass perfusion cardiovascular magnetic resonance parameters as surrogate markers for left ventricular diastolic dysfunction: a validation against cardiac catheterization.
Guo X; Gong C; Song R; Wan K; Han Y; Chen Y
Eur Radiol; 2022 Dec; 32(12):8131-8139. PubMed ID: 35779091
[TBL] [Abstract][Full Text] [Related]
13. Omics and Extreme Phenotyping Reveal Longitudinal Association Between Left Atrial Size and Pulmonary Vascular Resistance in Group 2 Pulmonary Hypertension.
Kelly NJ; Newhouse D; Chapagain H; Patel A; Tang Y; Howard A; Kirillova A; Kim HJ; Rahman H; El Khoury W; Nouraie SM; Hickey G; Sade LE; Jain S; Chan SY
J Am Heart Assoc; 2023 Dec; 12(23):e031746. PubMed ID: 38014658
[TBL] [Abstract][Full Text] [Related]
14. Combined Post- and Precapillary Pulmonary Hypertension in Patients With Heart Failure.
Rezaee ME; Nichols EL; Sidhu M; Brown JR
Clin Cardiol; 2016 Nov; 39(11):658-664. PubMed ID: 27768231
[TBL] [Abstract][Full Text] [Related]
15. [2022 ESC/ERS guidelines on the diagnostics and treatment of pulmonary hypertension : A focussed review].
Rosenkranz S
Herz; 2023 Feb; 48(1):23-30. PubMed ID: 36648489
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Pulmonary Hypertension Using 4D Flow MRI.
Cerne JW; Pathrose A; Gordon DZ; Sarnari R; Veer M; Blaisdell J; Allen BD; Avery R; Markl M; Ragin A; Carr JC
J Magn Reson Imaging; 2022 Jul; 56(1):234-245. PubMed ID: 34694050
[TBL] [Abstract][Full Text] [Related]
17. Haemodynamic mechanisms and long-term prognostic impact of pulmonary hypertension in patients with severe aortic stenosis undergoing valve replacement.
Weber L; Rickli H; Haager PK; Joerg L; Weilenmann D; Brenner R; Taramasso M; Baier P; Maisano F; Maeder MT
Eur J Heart Fail; 2019 Feb; 21(2):172-181. PubMed ID: 30328215
[TBL] [Abstract][Full Text] [Related]
18. The Diagnostic Challenge of Group 2 Pulmonary Hypertension.
Naeije R; D'Alto M
Prog Cardiovasc Dis; 2016; 59(1):22-9. PubMed ID: 27195751
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and haemodynamic profiles of pulmonary hypertension in cardiac amyloidosis.
Slivnick J; Zareba KM; Varghese J; Truong V; Wallner AL; Tong MS; Hummel C; Mazur W; Rajpal S
Open Heart; 2022 Mar; 9(1):. PubMed ID: 35246499
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary Hypertension in Heart Failure.
Jang AY; Park SJ; Chung WJ
Int J Heart Fail; 2021 Jul; 3(3):147-159. PubMed ID: 36262642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
